hbig

美 　英

• 網(wǎng)絡(luò)乙肝免疫球蛋白(hepatitis B immune globulin)；乙型肝炎免疫球蛋白；注射乙型肝炎免疫球蛋白

例句

In conclusion, we confirm the efficacy of long-term HBIG immunoprophylaxis.

結(jié)論是我們確認(rèn)了長(zhǎng)期接種乙肝免疫球蛋白的療效。

RESULTS: Between February 1996 and October 2004, 147 patients received low-dose HBIG plus lamivudine.

結(jié)果：在1996年2月到2004年10月間，共有147名或者接受了低劑量HBIG合用拉米夫定療法。

All the infants were given HBIg within 12 hours postpartum, and received HBV vaccine at 0, 1 and 3 months.

所有的嬰兒產(chǎn)后12小時(shí)內(nèi)給予乙肝免疫球蛋白，并收到0,1和3個(gè)月乙肝疫苗。

Median follow-up post-HBIG discontinuation was 40 (range, 5-51) months.

在停用HBIG后平均隨訪40個(gè)月（范圍為5-51個(gè)月）。

Probability of HBV recurrence was 0% and 9% at 2 and 4 years after HBIG discontinuation.

停用HBIG后第二年和第四年的乙肝復(fù)發(fā)概率分別為0%和9%。

Study on interruption of the vertical transmission of HBV by HBIG

應(yīng)用HBIG阻斷乙肝病毒母嬰傳播的研究